DK1372608T3 - Medicinske aerosolformuleringer - Google Patents

Medicinske aerosolformuleringer

Info

Publication number: DK1372608T3
Authority: DK; Denmark
Prior art keywords: aerosol formulations; salts; medical aerosol; medical; dosing
Prior art date: 2001-03-30

Application number

DK02701145T

Other languages

English (en)

Inventor

Rudi Mueller-Walz

Carsten Niederlaender

Original Assignee

Jagotec Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-30

Filing date

2002-03-11

Publication date

2007-12-27

2002-03-11 Application filed by Jagotec Ag filed Critical Jagotec Ag

2007-12-27 Application granted granted Critical

2007-12-27 Publication of DK1372608T3 publication Critical patent/DK1372608T3/da

Links

239000000443 aerosol Substances 0.000 title abstract 2
238000009472 formulation Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical class CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 abstract 2
239000000725 suspension Substances 0.000 abstract 2
235000021314 Palmitic acid Nutrition 0.000 abstract 1
235000021355 Stearic acid Nutrition 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000012752 auxiliary agent Substances 0.000 abstract 1
159000000007 calcium salts Chemical class 0.000 abstract 1
150000005828 hydrofluoroalkanes Chemical class 0.000 abstract 1
159000000003 magnesium salts Chemical class 0.000 abstract 1
230000005226 mechanical processes and functions Effects 0.000 abstract 1
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 abstract 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000008117 stearic acid Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
150000003751 zinc Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dispersion Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

DK02701145T 2001-03-30 2002-03-11 Medicinske aerosolformuleringer DK1372608T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CH6012001		2001-03-30
CH15272001		2001-08-20
PCT/CH2002/000145 WO2002078671A1 (de)	2001-03-30	2002-03-11	Medizinische aerosolformulierungen

Publications (1)

Publication Number	Publication Date
DK1372608T3 true DK1372608T3 (da)	2007-12-27

Family

ID=25737693

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02701145T DK1372608T3 (da)	2001-03-30	2002-03-11	Medicinske aerosolformuleringer

Country Status (22)

Country	Link
US (1)	US20040101483A1 (da)
EP (1)	EP1372608B1 (da)
JP (1)	JP4824267B2 (da)
CN (1)	CN100496608C (da)
AT (1)	ATE375142T1 (da)
AU (1)	AU2002234476B2 (da)
CA (1)	CA2442415C (da)
CY (1)	CY1107128T1 (da)
CZ (1)	CZ301676B6 (da)
DE (1)	DE50211045D1 (da)
DK (1)	DK1372608T3 (da)
ES (1)	ES2292713T3 (da)
HU (1)	HU229798B1 (da)
NO (1)	NO332848B1 (da)
NZ (1)	NZ528640A (da)
PL (1)	PL207377B1 (da)
PT (1)	PT1372608E (da)
RO (1)	RO121172B1 (da)
RU (1)	RU2294737C2 (da)
SK (1)	SK286394B6 (da)
WO (1)	WO2002078671A1 (da)
ZA (1)	ZA200307161B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070212422A1 (en) *	1999-11-10	2007-09-13	Manfred Keller	Dry powder for inhalation
WO2003024396A2 (en)	2001-09-17	2003-03-27	Glaxo Group Limited	Dry powder medicament formulations
GB0208609D0 (en) *	2002-04-13	2002-05-22	Glaxo Group Ltd	Compositions
DE60336089D1 (de) *	2002-12-10	2011-03-31	Sunovion Pharmaceuticals Inc	Aerosolformulierung umfassend Levalbuterol L-Tartratsalz
GB0316335D0 (en) *	2003-07-11	2003-08-13	Glaxo Group Ltd	Pharmaceutical formulations
JP2009514779A (ja) *	2003-07-11	2009-04-09	グラクソグループリミテッド	医薬製剤
GB0323684D0 (en)	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0323685D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0324918D0 (en) *	2003-10-24	2003-11-26	Glaxo Group Ltd	Composition
EP1713473B1 (en)	2004-02-06	2013-03-13	MEDA Pharma GmbH & Co. KG	The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
WO2005074982A2 (en)	2004-02-06	2005-08-18	Meda Pharma Gmbh & Co. Kg	Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
RU2438660C2 (ru)	2004-02-06	2012-01-10	Меда Фарма Гмбх Унд Ко. Кг	Комбинация и фармацевтический препарат для лечения воспалительных и обструктивных заболеваний дыхательных путей
GB0409703D0 (en) *	2004-04-30	2004-06-02	Vectura Ltd	Pharmaceutical compositions
GB0426301D0 (en) *	2004-11-30	2004-12-29	Vectura Ltd	Pharmaceutical formulations
GB0501956D0 (en) *	2005-01-31	2005-03-09	Arrow Internat	Nebulizer formulation
ES2570332T3 (es)	2005-03-16	2016-05-17	Meda Pharma Gmbh & Co Kg	La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias
ATE529399T1 (de)	2005-11-10	2011-11-15	Nicholas S Bodor	Sanfte anticholinerge ester
NZ591969A (en)	2005-12-21	2012-05-25	Meda Pharma Gmbh & Co Kg	Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases
AU2012200449B2 (en) *	2005-12-21	2013-07-25	Meda Pharma Gmbh & Co Kg	Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
GB0602897D0 (en) *	2006-02-13	2006-03-22	Jagotec Ag	Improvements In Or Relating To Dry Powder Inhaler Devices
GB0622818D0 (en) *	2006-11-15	2006-12-27	Jagotec Ag	Improvements in or relating to organic compounds
GB0625303D0 (en) *	2006-12-19	2007-01-24	Jagotec Ag	Improvements in and relating to metered dose inhalers
MX337126B (es)	2009-05-29	2016-02-12	Pearl Therapeutics Inc	Administracion respiratoria de agentes activos.
AU2015201864A1 (en) *	2009-05-29	2015-04-30	Pearl Therapeutics, Inc.	Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
AU2015201037C1 (en) *	2009-05-29	2017-07-27	Pearl Therapeutics, Inc.	Respiratory delivery of active agents
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918150D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved formulations
GB0918149D0 (en)	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation
ES2467928T3 (es) *	2009-12-23	2014-06-13	Chiesi Farmaceutici S.P.A.	Formulación en aerosol para EPOC
WO2011076842A2 (en)	2009-12-23	2011-06-30	Chiesi Farmaceutici S.P.A.	Aerosol formulation for copd
UA113832C2 (xx)	2009-12-23	2017-03-27		Комбінаційна терапія для хозл
JP5513177B2 (ja) *	2010-03-08	2014-06-04	共同印刷株式会社	湿度インジケータとその製造方法、該製造方法に用いる湿度インジケータ用塗料
CN102416179B (zh)	2010-09-28	2014-05-07	益得生物科技股份有限公司	用于哮喘的吸入性复方组合物
RU2629085C2 (ru)	2011-10-11	2017-08-24	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Кристаллические микрочастицы бета-агониста, покрытые жирной кислотой
CN102362860A (zh) *	2011-10-27	2012-02-29	江阴长风医药科技有限公司	以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
KR102391332B1 (ko)	2013-03-15	2022-04-26	펄 테라퓨틱스 인코포레이티드	미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
CN109069390A (zh) *	2016-04-11	2018-12-21	苏文生命科学有限公司	格隆溴铵的外用喷雾制剂

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1096357A (en) *	1965-02-11	1967-12-29	Fisons Pharmaceuticals Ltd	Aerosol compositions
JPS55361B1 (da) *	1970-09-17	1980-01-08
US5874063A (en) *	1991-04-11	1999-02-23	Astra Aktiebolag	Pharmaceutical formulation
SE9302777D0 (sv) *	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
EP0561166A1 (de) *	1992-03-17	1993-09-22	ASTA Medica Aktiengesellschaft	Dosieraerosole enthaltend den Wirkstoff D-18024 und verwandte Strukturen
MX9304585A (es) *	1992-07-31	1994-03-31	Glaxo Group Ltd	Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
JPH06135815A (ja) *	1992-10-30	1994-05-17	Shiseido Co Ltd	経皮吸収抑制組成物
ZA939195B (en) *	1992-12-09	1995-06-08	Boehringer Ingelheim Pharma	Stabilized medicinal aerosol solution formulations
DE4321288A1 (de) *	1993-06-26	1995-01-05	Solvay Fluor & Derivate	Zusammensetzungen mit chlorfreien, gegebenenfalls wasserstoffhaltigen Fluorkohlenwasserstoffen
DK0731688T3 (da) *	1993-12-02	2003-06-23	Abbott Lab	Aerosol-lægemiddelformuleringer til anvendelse med CFC-frie drivmidler
US5589156A (en) *	1994-05-02	1996-12-31	Henry; Richard A.	Prilocaine and hydrofluourocarbon aerosol preparations
GB9425160D0 (en) *	1994-12-10	1995-02-08	Glaxo Group Ltd	Medicaments
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
EP0806940B1 (en) *	1994-12-22	2003-04-09	AstraZeneca AB	Aerosol drug formulations
JP3707107B2 (ja) *	1995-09-18	2005-10-19	鈴木油脂工業株式会社	薬剤分散液及びその製造方法
US6054488A (en) *	1996-06-11	2000-04-25	3M Innovative Properties Company	Medicinal aerosol formulations of formoterol
US6261472B1 (en) *	1996-11-04	2001-07-17	E. I. Du Pont De Nemours And Company	Azeotrope-like compositions containing fluoroethane
US6361938B1 (en) *	1996-11-08	2002-03-26	Elan Corporation, Plc	Peptides which enhance transport across tissues and methods of identifying and using the same
AU725625B2 (en) *	1997-01-30	2000-10-19	Alpenstock Holdings Limited	A composition
AU718967B2 (en) *	1997-02-05	2000-05-04	Jagotec Ag	Medical aerosol formulations
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6451285B2 (en) *	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
JP4570251B2 (ja) *	1998-07-24	2010-10-27	ヤゴテックアーゲー	医薬用エーロゾル製剤
CN1150890C (zh) *	1998-08-04	2004-05-26	杰格研究股份公司	药用气溶胶制剂
US7521068B2 (en) *	1998-11-12	2009-04-21	Elan Pharma International Ltd.	Dry powder aerosols of nanoparticulate drugs
US6926911B1 (en) *	1998-12-22	2005-08-09	The University Of North Carolina At Chapel Hill	Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
GB9903759D0 (en) *	1999-02-18	1999-04-14	Novartis Ag	Organic compounds
US20060257324A1 (en) *	2000-05-22	2006-11-16	Chiesi Farmaceutici S.P.A.	Pharmaceutical solution formulations for pressurised metered dose inhalers
JP5392880B2 (ja) *	2000-05-22	2014-01-22	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	加圧式定量吸入器のための安定な製薬学的溶液製剤
AU2001278115A1 (en) *	2000-08-04	2002-02-18	Longwood Pharmaceutical Research, Inc.	Formulations of mometasone and a bronchodilator for pulmonary administration
NZ526059A (en) *	2000-11-30	2005-05-27	Vectura Ltd	Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition
TWI324934B (en) *	2001-08-28	2010-05-21	Schering Corp	Pharmaceutical compositions for the treatment of asthma
EP3384931B1 (en) *	2002-03-01	2019-07-24	Chiesi Farmaceutici S.p.A.	Formoterol superfine formulation
US7582284B2 (en) *	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
GB0323684D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0323685D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0918150D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved formulations
GB0918149D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation

2002
- 2002-03-11 NZ NZ528640A patent/NZ528640A/en not_active IP Right Cessation
- 2002-03-11 RU RU2003131676/15A patent/RU2294737C2/ru not_active IP Right Cessation
- 2002-03-11 CN CNB028073827A patent/CN100496608C/zh not_active Expired - Fee Related
- 2002-03-11 PL PL362797A patent/PL207377B1/pl unknown
- 2002-03-11 AU AU2002234476A patent/AU2002234476B2/en not_active Ceased
- 2002-03-11 ES ES02701145T patent/ES2292713T3/es not_active Expired - Lifetime
- 2002-03-11 RO ROA200300799A patent/RO121172B1/ro unknown
- 2002-03-11 PT PT02701145T patent/PT1372608E/pt unknown
- 2002-03-11 JP JP2002576937A patent/JP4824267B2/ja not_active Expired - Fee Related
- 2002-03-11 AT AT02701145T patent/ATE375142T1/de active
- 2002-03-11 DK DK02701145T patent/DK1372608T3/da active
- 2002-03-11 US US10/473,874 patent/US20040101483A1/en not_active Abandoned
- 2002-03-11 CZ CZ20032915A patent/CZ301676B6/cs not_active IP Right Cessation
- 2002-03-11 HU HU0401250A patent/HU229798B1/hu not_active IP Right Cessation
- 2002-03-11 WO PCT/CH2002/000145 patent/WO2002078671A1/de not_active Ceased
- 2002-03-11 SK SK1334-2003A patent/SK286394B6/sk not_active IP Right Cessation
- 2002-03-11 CA CA2442415A patent/CA2442415C/en not_active Expired - Fee Related
- 2002-03-11 EP EP02701145A patent/EP1372608B1/de not_active Expired - Lifetime
- 2002-03-11 DE DE50211045T patent/DE50211045D1/de not_active Expired - Lifetime
2003
- 2003-09-12 ZA ZA2003/07161A patent/ZA200307161B/en unknown
- 2003-09-26 NO NO20034323A patent/NO332848B1/no not_active IP Right Cessation
2008
- 2008-01-08 CY CY20081100021T patent/CY1107128T1/el unknown

Also Published As

Publication number	Publication date
ZA200307161B (en)	2005-01-26
CY1107128T1 (el)	2012-10-24
EP1372608A1 (de)	2004-01-02
NO20034323D0 (no)	2003-09-26
RU2003131676A (ru)	2005-02-10
HUP0401250A3 (en)	2008-04-28
CA2442415A1 (en)	2002-10-10
WO2002078671A1 (de)	2002-10-10
CZ20032915A3 (en)	2004-06-16
NZ528640A (en)	2004-06-25
HK1064295A1 (zh)	2005-01-28
HU229798B1 (en)	2014-07-28
ATE375142T1 (de)	2007-10-15
CN100496608C (zh)	2009-06-10
NO332848B1 (no)	2013-01-21
CZ301676B6 (cs)	2010-05-19
JP4824267B2 (ja)	2011-11-30
CA2442415C (en)	2010-07-20
AU2002234476C1 (en)	2002-10-15
AU2002234476B2 (en)	2006-04-27
PL207377B1 (pl)	2010-12-31
SK286394B6 (sk)	2008-09-05
DE50211045D1 (de)	2007-11-22
PL362797A1 (en)	2004-11-02
PT1372608E (pt)	2008-01-04
RO121172B1 (ro)	2007-01-30
ES2292713T3 (es)	2008-03-16
JP2004525148A (ja)	2004-08-19
US20040101483A1 (en)	2004-05-27
HUP0401250A2 (hu)	2004-11-29
SK13342003A3 (sk)	2004-08-03
NO20034323L (no)	2003-09-26
CN1499958A (zh)	2004-05-26
RU2294737C2 (ru)	2007-03-10
EP1372608B1 (de)	2007-10-10

Publication	Publication Date	Title
DK1372608T3 (da)	2007-12-27	Medicinske aerosolformuleringer
ATE373422T1 (de)	2007-10-15	Mikroemulsionbildende herbizidkonzentrate, mikroemulsionen und verfahren
ATE302616T1 (de)	2005-09-15	Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
BR0215380A (pt)	2004-12-07	Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
MD20070267A (en)	2008-06-30	Gastroresistant pharmaceutical formulation containing rifaximin
DK1102579T3 (da)	2003-07-14	Medicinske aerosolformuleringer
DE60207198D1 (de)	2005-12-15	Transplantate für die wiederherstellung von osteochondralen schäden
ECSP034774A (es)	2003-12-24	Pirazolopirimmidinas como agentes terapeuticos
ES2421948T3 (es)	2013-09-06	Compuestos y composiciones para suministrar agentes activos
ATE275393T1 (de)	2004-09-15	Feste dispersionen mit nitrataktiven wirkstoffen
BRPI0317696B8 (pt)	2021-05-25	composição para branqueamento
DE602005021770D1 (de)	2010-07-22	Indol-1-yl-essigsäurederivate
BRPI0414858A (pt)	2006-11-21	métodos para preparação de corpos de óleo compreendendo ingredientes ativos
EA200800927A1 (ru)	2008-10-30	КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
ES2422081T3 (es)	2013-09-06	Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
ITMI20022394A1 (it)	2004-05-14	Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
HUP0400520A2 (hu)	2004-07-28	Klindamicint és cinksót tartalmazó dermatológiai készítmények
BR0207725A (pt)	2004-03-23	Promotores do crescimento e/ou da diferenciação de células-tronco hematopoiéticas e/ou progenitores hematopoiéticos
BRPI0412453A (pt)	2006-10-17	uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo
UY27373A1 (es)	2003-02-28	Formulaciones de interferón beta-humano
ITMI20022549A1 (it)	2004-06-03	Composizione quaternaria comprendente come sostanza attiva la propolis.
DK1268522T3 (da)	2009-01-12	LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
PL1868631T3 (pl)	2010-10-29	Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
DE60033416D1 (de)	2007-03-29	Verwendung von hypoestoxiden als antiparasitäre mittel
ITMI20052515A1 (it)	2007-06-30	Formulazione farmaceutica per il trattamento della osteoartrite